Charlotte's Web Holdings (CWBHF) Change in Receivables (2021 - 2026)
Charlotte's Web Holdings' (CWBHF) quarterly Change in Receivables came in at $575000.0 in Q1 2026, up 45.94% year-on-year from $394000.0 in Q1 2025, and up 424.86% on a QoQ basis from -$177000.0 in Q4 2025.
Charlotte's Web Holdings (CWBHF) Change in Receivables (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 6 years of Change in Receivables data on file, last reported at $575000.0 in Q1 2026.
- On a quarterly basis, Change in Receivables rose 45.94% year-over-year to $575000.0 in Q1 2026; TTM through Mar 2026 was -$187000.0, a 242.75% decrease from a year earlier, with the FY2025 full-year figure at -$368000.0, down 1.94% from the prior year.
- Change in Receivables for Q1 2026 stood at $575000.0, up from -$177000.0 in the prior quarter.
- Over the last five years, Change in Receivables for CWBHF reached as high as $1.2 million in Q1 2023 and fell as low as -$2.2 million in Q1 2022.
- Historically, Change in Receivables has averaged -$134764.7 across 5 years, with a median of -$98000.0 in 2024.
- On a YoY basis, Change in Receivables climbed as much as 502.04% in 2025 and fell as far as 7415.38% in 2025.
- Year by year, Change in Receivables stood at -$18000.0 in 2022, then tumbled by 1800.0% to -$342000.0 in 2023, then plunged by 54.39% to -$528000.0 in 2024, then surged by 66.48% to -$177000.0 in 2025, then jumped by 424.86% to $575000.0 in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were $575000.0 in Q1 2026, -$177000.0 in Q4 2025, and -$951000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Charlotte's Web Holdings | 41.51 Mn | 36.32 Mn | 5.20 Mn | 575,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 575,000.00 |
| Mar 31, 2026 | 575,000.00 |
| Dec 31, 2025 | -177,000.00 |
| Dec 31, 2025 | -177,000.00 |
| Sep 30, 2025 | -951,000.00 |
| Sep 30, 2025 | -951,000.00 |
| Jun 30, 2025 | 366,000.00 |
| Jun 30, 2025 | 366,000.00 |
| Mar 31, 2025 | 394,000.00 |
| Mar 31, 2025 | 394,000.00 |
| Dec 31, 2024 | -528,000.00 |
| Dec 31, 2024 | -528,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 252,000.00 |
| Jun 30, 2024 | 252,000.00 |
| Mar 31, 2024 | -98,000.00 |
| Mar 31, 2024 | -98,000.00 |
| Dec 31, 2023 | -342,000.00 |
| Dec 31, 2023 | -342,000.00 |